Ligand Docking and Structure-based Virtual Screening in Drug Discovery

Author(s): Claudio N. Cavasotto, Andrew J. W. Orry

Journal Name: Current Topics in Medicinal Chemistry

Volume 7 , Issue 10 , 2007

Become EABM
Become Reviewer
Call for Editor


Ligand-docking-based methods are starting to play a critical role in lead discovery and optimization, thus resulting in new ‘drug-candidates’. They offer the possibility to go beyond the pool of existing active compounds, and thus find novel chemotypes. A brief tutorial on ligand docking and structure-based virtual screening is presented highlighting current problems and limitations, together with the most recent methodological and algorithmic developments in the field. Recent successful applications of docking-based tools for hit discovery, lead optimization and target-biased library design are also presented. Special consideration is devoted to ongoing efforts to account for protein flexibility in structure-based virtual screening.

Keywords: Ligand Docking, Structure-based Virtual Screening, Drug Discovery, Protein Flexibility, Scoring

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2007
Page: [1006 - 1014]
Pages: 9
DOI: 10.2174/156802607780906753
Price: $65

Article Metrics

PDF: 59